Metabolic Syndrome, Obesity
Conditions
Brief summary
Objective: The purpose of this study was to investigate the possible effects of green-plant thylakoid supplementation to a restricted diet intervention study in overweight to obese men. Methods: Overweight-obese men (BMI 25 - 35) were treated to a 30 E% restricted diet for one month, followed by one month of stabilization. Then they were divided in two treatment arms of one month each; one thylakoid-enriched diet (n=10) and one control diet (n=10). Body measurements and blood samples were taken throughout the study.
Detailed description
Twenty healthy, non-vegetarian, non-smoking Caucasian men were included in the study. Inclusion criteria: men aged 40 to 70 years with a BMI of 25 to 35. Exclusion criteria: Metabolic disturbances, bariatric surgery, recent diet, food allergies or treatment with antibiotics. The study protocol was approved by the Ethical Committee of Lund University, Sweden (#2006/361). The trial consisted of three periods: 1) diet-restriction period (one month) 2) stabilizing period (one month) 3) diet-restriction period with supplementation of thylakoids or placebo (one month). The two weight-losing periods included strict diet recommendation with -30 energy % (E%), and macronutrient composition: 55-65 E% carbohydrates, 10-15 E% protein and 25-35 E% fat. Sixty minutes of low intensive exercise per day was also required. During the stabilizing month participants were instructed to eat a healthy diet to be able to keep their achieved weight-loss. Day 0, 28, 56 and 84 the participants arrived after 12-hour fasting for blood sampling and anthropometric measurements. The blood samples were analyzed for plasma-glucose, insulin, HbA1c, inflammation markers, cholecystokinin, ghrelin, total cholesterol, LDL-cholesterol, HDL-cholesterol, and triacylglycerol.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy, overweight, non-vegetarian, non-smoking
Exclusion criteria
* Medication for metabolic disturbances, previous bariatric surgery, diabetes, had been on diet or treated with antibiotics during last 3 months, food-allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight | 3 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Waist circumference | 3 months | — |
| Blood lipids | 3 months | Total cholesterol, LDL, HDL and TAG are measured fasting every fourth week. |
| P-glucose and p-insulin | 3 months | P-glucose, p-insulin and HbA1c are measured fasting every fourth week. |
| Inflammatory markers | 3 months | CRP and TNF alpha are measured fasting every fourth week. |
| Appetite regulating hormones | 3 months | Ghrelin and leptin are measured fasting every fourth week. |